PA
Perceptive Advisors Portfolio holdings
AUM
$5.06B
1-Year Est. Return
314.02%
This Fund
S&P 500
1 Year Est. Return
+314.02%
AUM
$5.06B
AUM Growth
-$396M
(-7.3%)
Holding
136
Top Buys
| 1 | +$101M | |
| 2 | +$70.2M | |
| 3 | +$59.9M | |
| 4 |
Ionis Pharmaceuticals
IONS
|
+$39.8M |
| 5 |
BioCryst Pharmaceuticals
BCRX
|
+$33.2M |
Top Sells
| 1 | +$122M | |
| 2 | +$95.6M | |
| 3 | +$93.3M | |
| 4 |
FOLD
Amicus Therapeutics
FOLD
|
+$90.7M |
| 5 |
ATXS
Astria Therapeutics
ATXS
|
+$84.9M |
Sector Composition
| 1 | Healthcare | 99.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Savara
SVRA
$1.09B
| – | – |
-2,400,000
|
|
||
127
State Street SPDR S&P Biotech ETF
XBI
$7.86B
| – | – |
0
|
|
||
128
Xenon Pharmaceuticals
XENE
$5.16B
| – | – |
-200,791
|
|
||
|
LENZ
129
LENZ Therapeutics
LENZ
$222M
| – | – |
-50,000
|
|
||
|
TECX
130
Tectonic Therapeutic
TECX
$536M
| – | – |
0
|
|
||
|
GRAL
131
GRAIL Inc
GRAL
$2.59B
| – | – |
-237,342
|
|
||
|
SEPN
132
Septerna Inc
SEPN
$1.36B
| – | – |
-433,160
|
|
||
|
KMTS
133
Kestra Medical Technologies
KMTS
$1.05B
| – | – |
-285,000
|
|
||
|
CAI
134
Caris Life Sciences
CAI
$4.47B
| – | – |
-1,136,206
|
|
||
|
MPLT
135
MapLight Therapeutics
MPLT
$1.23B
| – | – |
-550,000
|
|